Clinical Trials
3 trialsNCT05204524 2022-01-24
Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma
ChineseAMS
Phase NA Unknown
NCT00003718 2014-01-06
Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00033709 2014-01-06
Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
National Cancer Institute (NCI)
Phase 2 Unknown